Society Of Cardiovascular/Interventional Radiology Highlights Cardiac Dimensions, Inc. AMADEUS(TM) Study as an Important “Late Breaking” Clinical Trial

KIRKLAND, Wash.--(BUSINESS WIRE)--The Society of Cardiovascular Angiography and Interventions (SCAI) will highlight Cardiac Dimensions®, Inc.’s AMADEUS™ study during its 32nd annual scientific sessions held in Las Vegas, NV later this week. AMADEUS™ (CARILLON™ Mitral Annuloplasty Device European Union Study) was a 30 patient safety and performance study of the CARILLON™ Mitral Contour System™ conducted at 6 centers in Germany, Poland, and the Netherlands. The study met its primary safety endpoint and its secondary performance endpoints both at 6 months. The results are scheduled for presentation May 8th by Prof. Dr. med. Tomasz Siminiak from the Poznan University of Medical Sciences, Cardiac and Rehabilitation hospital in Poznan, Poland. Prof. Siminiak was the leading enroller in the AMADEUS™ study and has implanted more CARILLON™ implants than anyone in the world.